Skip to main content

Table 1 HCMV IgG seroprevalence in solid organ transplant recipients and healthy transplant donors by age distribution

From: Human cytomegalovirus seroprevalence and titres in solid organ transplant recipients and transplant donors in Seoul, South Korea

Age (years)

Anti-HCMV IgG

SOT recipients (n = 2184)

Healthy transplant donors (n = 3015)

p-value

1–5

Positive

12 (80.0)

0 (0)

N/A

Negative

3 (20.0)

0 (0)

6–10

Positive

9 (75.0)

0 (0)

N/A

Negative

3 (25.0)

0 (0)

11–15

Positive

12 (70.6)

0 (0)

N/A

Negative

5 (29.4)

0 (0)

16–20

Positive

41 (93.2)

46 (54.8)

<0.001

Negative

3 (6.8)

38 (45.2)

21–25

Positive

54 (90.0)

162 (63.3)

<0.001

Negative

6 (10.0)

94 (36.7)

26–30

Positive

114 (96.6)

262 (78.9)

<0.001

Negative

4 (3.4)

70 (21.1)

31–35

Positive

133 (99.3)

307 (86.5)

<0.001

Negative

1 (0.7)

48 (13.5)

36–40

Positive

215 (99.1)

229 (89.8)

<0.001

Negative

2 (0.9)

26 (10.2)

41–60

Positive

1287 (99.8)

1088 (94.3)

<0.001

Negative

2 (0.2)

66 (5.7)

≥ 61

Positive

278 (100)

576 (99.5)

0.555

Negative

0 (0)

3 (0.5)

Total

Positive

2155 (98.7)

2670 (88.6)

<0.001

Negative

29 (1.3)

345 (11.4)

  1. Data are expressed as number (percent). Abbreviations: HCMV Human cytomegalovirus, IgG immunoglobulin G, N/A not available, SOT solid organ transplantation